| Pieces of the Federal Funding Puzzle Coming Together | | With one piece of the budget puzzle about to be put in place, at least temporarily, the FDA, National Institutes of Health (NIH) and other federal agencies can start planning for fiscal 2013. By a vote of 329-91, the House passed a continuing resolution that would fund federal agencies. Find out the details. |  |
| Health Care & Policy |  |  | | - Stem cell licenses granted to EMD
iPS Academia Japan, an affiliate of Kyoto University, granted EMD Millipore global, non-exclusive licensing rights to a number of patents related to induced pluripotent stem cells. EMD plans to develop and market the stem cells for research use. Mass High Tech (Boston) (9/17)       - Janssen's Zytiga lengthens survival in prostate cancer study
A late-stage study confirmed that Janssen Biotech's Zytiga, or abiraterone, extends overall survival of patients with metastatic castration-resistant prostate cancer that progressed after treatment with Sanofi's Taxotere, or docetaxel. Researchers said patients on Zytiga plus prednisone saw median overall survival of 15.8 months during median follow-up of 20 months, compared with 11.2 months for those on placebo plus prednisone. MedPage Today (free registration) (9/17) - Twitter proves a new frontier for biotech, pharma firms
Though the FDA has not issued long-awaited guidelines on drugmakers' social media interactions, many biotech and pharmaceutical firms are at least monitoring what gets said about them on Twitter and other platforms, experts say. Some fully embrace the medium, such as Biogen Idec Senior Vice President Michael Gilman, who uses Twitter as a news source and as a platform for discussions with entrepreneurs, venture capitalists and journalists. Others keep tabs on the conversation without joining in. Xconomy (9/17)  | Earn 2X rewards points on advertising costs with The Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, shipping
• 1X points on everything else
• Limited Time Offer: 50K bonus points when you spend $5K in your first 3 months of Card membership†
LEARN MORE AND APPLY †Terms & Restrictions Apply. |
  | Company & Financial News | | | |
| Food & Agriculture | | | | - Researchers create corn that could produce rare disease drug
Scientists in Canada and Australia have developed transgenic corn to synthesize the enzyme alpha-L-iduronidase, which is used to treat the rare disease mucopolysaccharidosis I. The work, reported in the journal Nature Communications, may lead to less expensive methods of making an enzyme replacement drug that can cost $300,000 a year or more. Reuters (9/18) | Industrial & Environmental | | | | - Diatoms hold potential for biofuel and materials production
A team of scientists at Oregon State University has secured a $2 million, four-year grant from the National Science Foundation to study the potential for diatoms to produce biofuel and other products. Diatoms have the ability to produce lipids for biofuels, as well as semiconductor materials and chitin fibers for industrial uses, said Greg Rorrer, who leads the university's School of Chemical, Biological and Environmental Engineering. "We believe that we can produce all of these products in one facility at the same time and move easily from one product to the other," Rorrer said. DomesticFuel.com (9/18) | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the e-newsletter.
| SmartQuote | | | |  | The well bred contradict other people. The wise contradict themselves."
--Oscar Wilde,
Irish writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, September 18, 2012
- Monday, September 17, 2012
- Friday, September 14, 2012
- Thursday, September 13, 2012
- Wednesday, September 12, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment